Checked
Leukemia Clinical Trials in Mississippi
Open studies with at least one site in the state
Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.
- Open studies
- 19
- With a site in Mississippi
- Most studies in
- Jackson
- 9 of the studies shown
Studies
19 of 19, recruiting studies first. Cities are where the study lists a Mississippi site.
- Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyRecruitingPhase 3NCT04269902· National Cancer Institute (NCI)
Columbus, Grenada, New Albany, Oxford and 1 more
- Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)RecruitingPhase 2NCT05554393· National Cancer Institute (NCI)
Columbus, Grenada, New Albany, Oxford and 1 more
- Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)RecruitingPhase 2NCT05554406· National Cancer Institute (NCI)
Columbus, Grenada, New Albany, Oxford and 1 more
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)RecruitingPhase 2NCT05564390· National Cancer Institute (NCI)
Columbus, Grenada, New Albany, Oxford and 1 more
- Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)RecruitingPhase 2NCT06317649· National Cancer Institute (NCI)
Columbus, Grenada, New Albany, Oxford and 1 more
- Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaRecruitingPhase 2NCT06317662· National Cancer Institute (NCI)
Jackson
- Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group StudiesRecruitingNCT00736749· Children's Oncology Group
Jackson
- A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).RecruitingPhase 3NCT05947851· Merck Sharp & Dohme LLC
Hattiesburg
- Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLLRecruitingPhase 3NCT07321652· Alliance for Clinical Trials in Oncology
Southhaven
- Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaRecruitingPhase 1, Phase 2NCT04925479· Novartis Pharmaceuticals
Jackson
- A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsRecruitingPhase 3NCT04293562· Children's Oncology Group
Jackson
- Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyRecruitingPhase 3NCT03959085· Children's Oncology Group
Jackson
- The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyRecruitingPhase 1, Phase 2NCT04726241· PedAL BCU, LLC
Jackson
- Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)RecruitingPhase 3NCT05183035· PedAL BCU, LLC
Jackson
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)RecruitingNCT01351545· Center for International Blood and Marrow Transplant Research
Jackson
- A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaRecruitingPhase 2NCT06588478· Loxo Oncology, Inc.
Gulfport
- Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer TreatmentRecruitingNCT01790152· Children's Oncology Group
Jackson
- Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)RecruitingPhase 2NCT04895436· AbbVie
Hattiesburg
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774· Massive Bio, Inc.
Hattiesburg
Other cancer studies in Mississippi
Frequently asked questions
- Are there leukemia clinical trials in Mississippi?
- Yes. 19 leukemia studies on ClinicalTrials.gov list at least one site in Mississippi and are recruiting, about to recruit or enrolling by invitation, including sites in Jackson, Southhaven, Columbus.
- What does recruiting mean?
- Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
- How do I join a clinical trial?
- Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.
Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/26/2026